USD 84.74
(-0.94%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 5.6 Billion USD | 18.11% |
2022 | 4.74 Billion USD | 2.06% |
2021 | 4.65 Billion USD | 58.23% |
2020 | 2.94 Billion USD | -19.72% |
2019 | 3.66 Billion USD | 14.72% |
2018 | 3.19 Billion USD | -0.37% |
2017 | 3.2 Billion USD | 2.99% |
2016 | 3.11 Billion USD | -0.4% |
2015 | 3.12 Billion USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 1.38 Billion USD | 0.02% |
2024 Q1 | 1.38 Billion USD | 2.14% |
2023 Q2 | 1.36 Billion USD | 4.44% |
2023 Q4 | 1.35 Billion USD | 4.97% |
2023 Q3 | 1.28 Billion USD | -5.43% |
2023 Q1 | 1.3 Billion USD | 11.54% |
2023 FY | 5.6 Billion USD | 18.11% |
2022 Q4 | 1.17 Billion USD | 0.34% |
2022 FY | 4.74 Billion USD | 2.06% |
2022 Q3 | 1.16 Billion USD | -3.16% |
2022 Q1 | 1.2 Billion USD | 0.17% |
2022 Q2 | 1.2 Billion USD | -0.33% |
2021 Q1 | 1.03 Billion USD | 17.83% |
2021 Q3 | 1.19 Billion USD | -2.05% |
2021 FY | 4.65 Billion USD | 58.23% |
2021 Q4 | 1.2 Billion USD | 0.92% |
2021 Q2 | 1.22 Billion USD | 18.33% |
2020 Q4 | 875 Million USD | 3.18% |
2020 Q1 | 872 Million USD | -4.49% |
2020 Q2 | 345 Million USD | -60.44% |
2020 Q3 | 848 Million USD | 145.8% |
2020 FY | 2.94 Billion USD | -19.72% |
2019 Q4 | 913 Million USD | -3.89% |
2019 Q2 | 947 Million USD | 11.15% |
2019 Q1 | 852 Million USD | -3.07% |
2019 FY | 3.66 Billion USD | 14.72% |
2019 Q3 | 950 Million USD | 0.32% |
2018 Q2 | 878 Million USD | -1.57% |
2018 FY | 3.19 Billion USD | -0.37% |
2018 Q4 | 879 Million USD | 54.75% |
2018 Q3 | 568 Million USD | -35.31% |
2018 Q1 | 892 Million USD | 8.78% |
2017 Q4 | 820 Million USD | 0.0% |
2017 FY | 3.2 Billion USD | 2.99% |
2016 FY | 3.11 Billion USD | -0.4% |
2015 FY | 3.12 Billion USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
AptarGroup, Inc. | 1.26 Billion USD | -343.877% |
Baxter International Inc. | 4.97 Billion USD | -12.722% |
Becton, Dickinson and Company | 9.15 Billion USD | 38.731% |
Bausch + Lomb Corporation | 2.5 Billion USD | -123.959% |
Haemonetics Corporation | 676.53 Million USD | -728.918% |
Envista Holdings Corp | 1.45 Billion USD | -286.621% |
ResMed Inc. | 2.6 Billion USD | -114.964% |
Teleflex Incorporated | 1.64 Billion USD | -240.508% |
Warby Parker Inc. | 365.22 Million USD | -1435.478% |
West Pharmaceutical Services, Inc. | 1.12 Billion USD | -396.629% |